Flashlight
Apr 1
Srivatsan Swaminathan, Gilbert H.L. Tang, et al.
A 73-year-old female with a history of rheumatic fever and severe mitral stenosis who had undergone TMVR presented with severe tricuspid regurgitation. 3D ICE-guided TTVR was performed, with a successful outcome.
CONSENSUS DOCUMENT
Mar 31
This consensus provides practical guidance on personalizing dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention to optimize clinical outcomes by balancing ischemic and bleeding risks.
open access
Trial Design
Mar 30
Dimytri A. Siqueira, Fausto Feres, et al.
The SURVIV trial is a randomized study comparing transcatheter mitral valve-in-valve and surgical redo-mitral valve replacement in patients with failed bioprosthetic mitral valves.
Research Correspondence
Mar 27
Yusuke Kobari, Ole De Backer, et al.
The study found that the use of an extended-length sheath during transfemoral transcatheter aortic valve implantation (TF-TAVI) in patients with a hostile aortic anatomy is feasible and may enhance procedural safety by potentially avoiding vascular and/or calcific/thromboembolic complications.
Editorial
Mar 25
Morton J. Kern, Derek Antoku
The editorial discusses the potential use of transvalvular hemodynamics, such as the stress aortic valve index (SAVI), to help guide decision-making around the need for aortic valve replacement in patients with moderate or mild aortic stenosis.
free
Original Research
Mar 23
Rob Eerdekens, Pim A.L. Tonino, et al.
This study evaluated symptomatic patients with moderate aortic stenosis and preserved ejection fraction using invasive and non-invasive assessments at rest and during stress. The stress aortic valve index strongly predicted the need for aortic valve intervention.
State-of-the-Art
Mar 18
Mia Ravn Jacobsen, Tobias Geisler, et al.
This review examines the prevalence, mechanisms, and management of leaflet thrombosis after transcatheter aortic valve implantation (TAVI), a minimally invasive procedure for severe aortic stenosis.
free
new issue
Mar 16
A State-of-the-Art on TAVI thrombosis; a novel stress aortic valve index; design and rationale of the SURVIV trial; extended-length introducer sheaths for TAVI; leaflet avulsion after UNICORN leaflet modification; 3D intracardiac echo-guided transcatheter tricuspid valve replacement; and more
Flashlight
Mar 20
Arif A. Khokhar, Ole De Backer, et al.
The content discusses the UNICORN technique for reducing the risk of coronary obstruction during redo-TAVI, highlighting the need for caution due to the unpredictable nature of complete leaflet avulsion and the potential benefits of orthotopic coronary wiring and stenting.
Original Research
Mar 13
Maxime Dubosq-Lebaz, Eric A. Secemsky, et al.
In a national cohort of Medicare beneficiaries with chronic limb-threatening ischemia, drug-coated devices were associated with reduced amputation, mortality, and reintervention compared to uncoated devices, without increased costs.
free
Editorial
Mar 13
Piotr Musiałek, Antonio Micari
A registry study comparing endovascular treatment options for peripheral artery disease in the femoropopliteal segment found a statistically significant benefit of drug-coated/drug-eluting devices in reducing major amputation/death and major adverse limb events.
free
Editorial
Mar 12
Javier Escaned, Guus de Waard
The study examined the relationship between coronary flow, stenosis severity, and microvascular resistance, confirming previous experimental observations and providing insights based on in-vivo measurements in a large patient cohort.
free
Original Research
Mar 11
Federico Marin, Giovanni Luigi De Maria, et al.
This study found that percutaneous coronary intervention (PCI) significantly reduces epicardial resistance, leading to a pronounced increase in hyperaemic flow, which can be predicted by fractional flow reserve (FFR). Resting flow remained unchanged due to compensatory increases in microvascular resistance.
Simultaneous Publication CRT 2026
Mar 10
David E Kandzari, Felix Mahfoud, et al.
In this pooled analysis of patients undergoing radiofrequency renal denervation, there were significant blood pressure changes after 36 months, with few adverse events, supporting long-term safety and efficacy in patients with uncontrolled hypertension.
open access
Expert Review
Mar 9
Isa Bijloo, Yolande Appelman, et al.
This review examines the diagnostic modalities for coronary dysfunction in patients with angina and non-obstructive coronary artery disease, finding that only coronary flow reserve can be reliably measured non-invasively, while invasive coronary function testing remains the gold standard.
free
